In 2016, Li et al. reported that SPS inhibited tumor growth by reducing the expression of AKT, p-AKT, and PI3K and increasing mRNA levels of Bax and Caspase-3 (Li J. Y. et al., 2016). The gene discussed is AKT1; the disease is neoplasm.